Glandular tissue–based versus anatomical landmark–based CTV delineation in postoperative breast cancer radiotherapy: a dosimetric comparison
Frontiers in Oncology · 29.05.2026 · 16
DOI: 10.3389/fonc.2026.1825988 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 29.05.2026. Verfasst von Chao Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Clinical Medicine for Oncology, Fujian Medical University, Fuzhou, China. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Precise delineation of clinical target volume (CTV) in postoperative breast cancer radiotherapy to ensure adequate target coverage while limiting radiation exposure to organs at risk (OARs). Anatomical landmark–based and glandular tissue–based approaches are widely used, but their dosimetric differences and practical implications remain under discussion.
Methods
This retrospective dosimetric study included breast cancer patients who underwent breast-conserving surgery with normal bilateral breast morphology. CT simulations (3-mm slice thickness) were imported into the Monaco 5.0 planning system. Two CTV delineation strategies were compared: anatomical landmark–based (CTV an ) following ESTRO guidelines, and glandular tissue–based (CTV gl ) using CT visualization. Planning target volume (PTV) was generated by applying a 0.5-cm retraction from the skin and a 0.5-cm uniform expansion. All contours were generated by a single senior radiation oncologist, and treatment plans were created by an experienced physicist. Dosimetric parameters for the heart, left lung, and contralateral breast were evaluated.
Results
A total of 48 patients (age 32–67 years; mean 49.35 ± 8.57) were included. CTV gl volumes were significantly smaller than CTV an volumes (432.87 ± 184.09 cc vs. 582.59 ± 232.55 cc; P < 0.001). Glandular-based delineation was associated with lower D max , higher D 98 , and reduced OARs exposure. Left lung V 20 , mean heart dose, heart V 40 , and contralateral breast(CB) D mean were all significantly lower in the CTV gl group ( P < 0.001). CTV volume showed significant positive associations with heart and contralateral-breast dose, whereas left-lung dose demonstrated weaker and more variable associations, reflecting the influence of anatomical and planning-related factors.
Conclusions
Glandular tissue–based delineation produced smaller target volumes and lower radiation exposure to adjacent organs compared with anatomical landmark–based delineation. These findings provide quantitative dosimetric evidence of differences between the two approaches; however, the clinical implications of these reductions cannot be inferred from this dosimetric analysis alone. Further studies incorporating normal tissue complication probability (NTCP) modeling and clinical outcomes are needed to determine their relevance for long-term toxicity and treatment decision-making.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Clinical Medicine for Oncology, Fujian Medical University, Fuzhou, China.
- Department of Oncology, Second Hospital of Sanming City, Sanming, China.
- Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, NHC Key Laboratory of Cancer Metabolism, Fuzhou, China.
Zitieren
APA
Li, C., Zhang, B., Huang, L., Wei, Q. M., & Qiu, S. F. (2026). Glandular tissue–based versus anatomical landmark–based CTV delineation in postoperative breast cancer radiotherapy: a dosimetric comparison. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1825988
Vancouver
Li C, Zhang B, Huang L, Wei QM, Qiu SF. Glandular tissue–based versus anatomical landmark–based CTV delineation in postoperative breast cancer radiotherapy: a dosimetric comparison. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1825988
BibTeX
@article{Li2026,
author = {Li, Chao and Zhang, Bin and Huang, Lin and Wei, Qiu-Ming and Qiu, Su-Fang},
title = {Glandular tissue–based versus anatomical landmark–based CTV delineation in postoperative breast cancer radiotherapy: a dosimetric comparison},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1825988}
}
EUVIMED